Melanom kliniske forsøg i Michigan
31 studier for Melanom søger deltagere på steder i Michigan.
Byer i Michigan
- Grand Rapids17 studier
- Ann Arbor12 studier
- Detroit11 studier
- Kalamazoo7 studier
- Wyoming6 studier
- Lansing3 studier
- Flint3 studier
- Waterford3 studier
- Muskegon3 studier
Officiel studietekst (engelsk)
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
- South Texas Accelerated Research Therapeutics (START), Grand Rapids
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT06270706Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- MyMichigan Medical Center Gratiot, Alma
- MyMichigan Medical Center Alpena, Alpena
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- og 68 flere
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 40 til 75 · Alle køn · Opdateret 2. okt. 2026 · NCT05334069BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- University of Michigan Rogel Cancer Center, Ann Arbor
- Bronson Battle Creek, Battle Creek
- og 23 flere
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT05136196A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
- University of Michigan, Ann Arbor
- Henry Ford Cancer Institute/Henry Ford Health System, Detroit
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT06246916Pan-tumor MRD Study
- The Cancer & Hematology Centers (CHC), Grand Rapids
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 24. sep. 2026 · NCT06605404Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma
- Bronson Battle Creek, Battle Creek
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
- Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids
- og 8 flere
RekruttererFase 3
Alder 75 og opefter · Alle køn · Opdateret 24. sep. 2026 · NCT07068074Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
- START Midwest, Grand Rapids
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 18. sep. 2026 · NCT05267626A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
- Local Institution - 0119, Ann Arbor
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 16. sep. 2026 · NCT07492680A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases
- University of Michigan Comprehensive Cancer Center, Ann Arbor
- Bronson Battle Creek, Battle Creek
- University of Michigan - Brighton Center for Specialty Care, Brighton
- og 15 flere
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 15. sep. 2026 · NCT04511013ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- Cancer & Hematology Centers of Western Michigan, Grand Rapids
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 14. sep. 2026 · NCT05059444Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
- Wayne State University - Barbara Ann Karmanos Cancer Institute, Detroit
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 4. sep. 2026 · NCT07287917A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
- Brigitte Harris Cancer Pavilion BHCP, Detroit
- START Midwest, LLC, Grand Rapids
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 2. sep. 2026 · NCT07070232Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- C S Mott Children's Hospital, Ann Arbor
RekruttererFase 1/2
12 Months – 30 Years · Alle køn · Opdateret 25. aug. 2026 · NCT04851119Project: Every Child for Younger Patients With Cancer
- C S Mott Children's Hospital, Ann Arbor
- Bronson Battle Creek, Battle Creek
- Children's Hospital of Michigan, Detroit
- og 14 flere
RekruttererObservationsstudie
Op til 25 år · Alle køn · Opdateret 25. aug. 2026 · NCT02402244A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
- Research Site, Grand Rapids
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 19. aug. 2026 · NCT07115043A Study of MGC026 in Participants With Advanced Solid Tumors
- START Midwest, Grand Rapids
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 11. aug. 2026 · NCT06242470A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
- Karmanos Cancer Institute, Detroit
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 11. aug. 2026 · NCT05592626A Study of mRNA-4106 or mRNA-4200 Administered Alone or in Combination With Anti-Cancer Agents in Participants With Solid Tumors
- START Midwest, Grand Rapids
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 10. aug. 2026 · NCT06880549Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
- Henry Ford Cancer Institute, Detroit
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 29. jul. 2026 · NCT04198766Neoadjuvant Darovasertib in Primary Uveal Melanoma
- W Kellogg Eye Center, Ann Arbor
- The Cancer and Hematology Centers of West Michigan (CHCWM), Grand Rapids
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 6. maj 2026 · NCT07015190A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body
- Start Midwest Cancer Research, Grand Rapids
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 28. apr. 2026 · NCT06413680Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
- MyMichigan Medical Center Gratiot, Alma
- MyMichigan Medical Center Alpena, Alpena
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- og 19 flere
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 17. mar. 2026 · NCT06418204A Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMBD-501 in Patients With HER3-Expressing Solid Tumors
- Research Site, Farmington Hills
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 2. mar. 2026 · NCT06956690A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
- Research Site 129, Detroit
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 21. nov. 2025 · NCT05914116SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Ann Arbor
- Massive Bio SYNERGY-AI site, Lansing
RekruttererObservationsstudie
Alle aldre · Alle køn · Opdateret 28. okt. 2025 · NCT03452774Excision of Lymph Node Trial (EXCILYNT) (Mel69)
- University of Michigan, Ann Arbor
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 17. sep. 2025 · NCT05839912A Beta-only IL-2 ImmunoTherapY Study
- Karmanos Cancer Institute, Detroit
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 9. jul. 2025 · NCT05086692A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors
- Henry Ford Cancer Institute, Detroit
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 18. maj 2025 · NCT05970497A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
- Barbara Ann Karmanos Cancer Hospital dba Karmanos Cancer Center, Detroit
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 13. feb. 2025 · NCT05669430A Study of IBI363 in Subjects with Advanced Solid Malignancies
- Michigan Hematology & Oncology Consultants - MedOnc Dearborn, Dearborn
- Michigan Hematology & Oncology Consultants - MedOnc Troy, Troy
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 19. dec. 2024 · NCT06281678Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
- University of Michigan Medical Center, Ann Arbor
- University of Michigan - Brighton Center for Specialty Care, Brighton
- Mercy Health Saint Mary's, Grand Rapids
- og 2 flere
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 27. nov. 2024 · NCT03860883Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.